Xenon Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:XENE) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -54.38 M-61.65 M-64.23 M-71.75 M-81.48 M -279.12 M Cash from investing activities 98.5 M34.51 M82.26 M38.53 M62.7 M 218 M Cash from financing activities 12.13 M1.15 M65 K2.36 M113.54 M 117.11 M Free cash flow -55.17 M-61.7 M-64.39 M-72.03 M-81.8 M -279.92 M

News

Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why

Wedbush lowers Xenon Pharmaceuticals stock price target to $63

BofA raises Xenon Pharmaceuticals price target on trial success

Xenon Pharmaceuticals closes $747.5M public offering

Xenon Pharmaceuticals prices $650M public offering at $57/share

XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study

Citizens reiterates Rapport Therapeutics stock rating on seizure drug potential

Jefferies raises Xenon Pharmaceuticals stock price target on epilepsy drug potential

Xenon Pharmaceuticals launches $500 million stock offering

Xenon Pharmaceuticals Inc. (XENE) Discusses Positive Top Line Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures Transcript

Avago, Lumentum among market cap stock movers on Monday

Baird raises Xenon Pharmaceuticals price target to $97 on trial data